Evaluate the Efficacy and Safety of HIF-PHI for the Treatment of Anemia and Risks of Cardiovascular and Cerebrovascular Events in ESRD Newly Initiated Dialysis Patients
Clinical trial NCT04134026 · UNKNOWN
Trial details
- NCT number
- NCT04134026
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2023-10-19
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.